UCB U.S. News

UCB's Global Corporate Website

Welcome to UCB in the United States

Healthcare Professionals

Patients

Investors

27 UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

Read More Share:

Jun

20 UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference

Read More Share:

Jun

13 Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis

Read More Share:

Jun

04 Resources for Resilience: Dravet Syndrome Awareness Month for Families Living with DEEs

Read More Share:

Jun

02 Partnering with Patient Communities to Advance HS Awareness and Care

Read More Share:

May

30 Recognizing Myasthenia Gravis Month – The Importance of Addressing Unmet Patient Needs

At UCB, we work 365-days-a-year to find new ways to deliver solutions, peace of mind, and opportunities to people living with severe diseases because everyone deserves to live the best life they can.

Read More Share:

Apr

22 Earth Day 2025: Advancing Our Commitment to a Healthier Planet

Read More Share:

Mar

31 The First UCB US Rare Disease Connect in Neurology (RDCN) Annual Summit Launches at American Academy of Neurology 2025

Read More Share:

Mar

28 Join UCB at the MGFA National Patient Conference and Visit Our Experience Room

Read More Share:

Mar

27 UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star

Read More Share:

Categories

Archives

Jun

27

UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

Jun

20

UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference

Jun

13

Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis

Jun

04

Resources for Resilience: Dravet Syndrome Awareness Month for Families Living with DEEs

Jun

02

Partnering with Patient Communities to Advance HS Awareness and Care

May

30

Recognizing Myasthenia Gravis Month – The Importance of Addressing Unmet Patient Needs

Apr

22

Earth Day 2025: Advancing Our Commitment to a Healthier Planet

Mar

31

The First UCB US Rare Disease Connect in Neurology (RDCN) Annual Summit Launches at American Academy of Neurology 2025

Mar

28

Join UCB at the MGFA National Patient Conference and Visit Our Experience Room

Mar

27

UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star

Choose Country

UCB in the U.S.

Innovation

Disease Areas

Sustainability

Newsroom

Contact

Categories

Archives

Jun

27

UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

Jun

20

UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference

Jun

13

Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis

Jun

04

Resources for Resilience: Dravet Syndrome Awareness Month for Families Living with DEEs

Jun

02

Partnering with Patient Communities to Advance HS Awareness and Care

May

30

Recognizing Myasthenia Gravis Month – The Importance of Addressing Unmet Patient Needs

Apr

22

Earth Day 2025: Advancing Our Commitment to a Healthier Planet

Mar

31

The First UCB US Rare Disease Connect in Neurology (RDCN) Annual Summit Launches at American Academy of Neurology 2025

Mar

28

Join UCB at the MGFA National Patient Conference and Visit Our Experience Room

Mar

27

UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star

Choose Country

UCB in the U.S.

Innovation

Disease Areas

UCB Worldwide

Sustainability

Newsroom

Contact